All insider buying reported in the week of 10/20/2024.
All Insider buyers of the week.
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-15 | Aprea Therapeutics, Inc. | Gilad Oren
(President/CEO) |
P | Common Stock | A | 250 | $2.90 - $2.90 | $725 |
| 2024-10-14 | Aprea Therapeutics, Inc. | Duey Marc
(Director) |
P | Common Stock | A | 190 | $2.58 - $2.58 | $490 |
| 2024-10-11 | Fundrise Income Real Estate Fund, LLC | Starr Gayle P
(Director) |
P | Common Shares | A | 40 | $9.99 - $9.99 | $408 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |